Boots, be gone! With spring officially making its debut and summer at the tip of our fingers, I’m devoting all…
Read More »Lilly
Every editorial product is independently selected by our editors. If you buy something through our links, we may earn commission.…
Read More »herkisi The sheer size and dominance of the “Magnificent 7” club has been well documented, especially in light of their…
Read More »Bloomberg—Isomorphic Labs, a subsidiary of Alphabet Inc., said it entered into strategic research collaboration agreements with Novartis AG and Eli…
Read More »hapabapa/iStock Editorial via Getty Images Sales from Eli Lilly’s (NYSE:LLY) newly approved weight loss medication, Zepbound, could reach $4.1B by…
Read More »It took some time, but Novo Nordisk may be facing the first real test of its dominance in the weight…
Read More »